While FDA guidance (“Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices”) states that ...
Please provide your email address to receive an email when new articles are posted on . Most patients supported the acceptability of an informed opt-out consent model for real-world data collection.
Clayton Irvine, PharmD, MBA, MS, explains that leveraging high-quality, real-world data; cross-institutional collaboration; standardized care pathways; advanced technologies; and integrated ...
The integration of real-world data (RWD) into protocol feasibility and site selection has emerged as a clinical trial game-changer in recent years. Traditionally relying heavily on data from carefully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results